Instructions to Authors

Types of papers

Types of papers that can be submitted for consideration by the Editorial Board include:

  1. Brief review articles on current and/or ambiguous topics related to Atherosclerosis and cardiovascular disease without abstract, written after invitation of the Editorial Board. Three key-words should be listed.
  2. Review articles.Detailed surveys of medical subjects with the emphasis on current points of view related to atherosclerosis and cardiovascular disease.
  3. Research articles.Reports on clinical trials or experimental work and epidemiological prospective or retrospective research in topics related to atherosclerosis, based on a research protocol described in detail in the methodology section. The results of the study should not have been previously published (except in abstract form). Clinical and epidemiological studies with particular interest to Greek healthcare workers will be given priority. Quite exceptionally original papers published in distinguished foreign journals by Greek scientists especially when their results are relevant for the Greek medical community can be republished in “Journal of Atherosclerosis Prevention and Treatment” after been approved by the Editorial Board. These papers must be translated by the authors, who also have to obtain written permission by the copyright owners.
  4. Clinical points of view. A diagnostic, therapeutic or epidemiological approach to several clinical syndromes of the atherosclerotic disease; the data for and against should be in algorithmic form.
  5. Case reports.Reports on new or very rare clinical cases of atherosclerotic disease, new diagnostic criteria or new therapeutic methods with proven results.
  6. Conferences, seminars, round tables. Abstracts or short texts of speakers participated in conferences, seminars or round tables related to atherosclerosis organized by, or been under, the auspices of the Hellenic Atherosclerosis Society or abstracts presented as posters in conferences organized by the Hellenic Atherosclerosis Society.
  7. Book presentations. They should refer to the title of the book, the authors’ name(s), the number of pages, the name of the publisher, the date and the place of publication and the price.
  8. Letters containing comments on papers published in the journal, preliminary results, remarks about untoward effects of drugs, judgments concerning the journal etc. They must be signed. Previous or duplicate publication.

Length of papers

Editorials not exceed the 1,000 words. Review articles should not exceed 5,000 words including tables, legends to the figures and references and could include up to three figures. However, the Editorial Board may allow the publication of longer reviews upon judgement. Original papers should be shorter, generally not exceeding 4,000 words including tables, legends to the figures and references and could include up to six figures. Clinical points of view should not exceed 1,500 words, case reports 1,000 words and letters to the Editor 500 words.

Assembling a paper

“Journal of Atherosclerosis Prevention and Treatment” has agreed to conform to the Uniform Requirements for Manuscripts submitted to Biomedical Journals (Vancouver System) and its guidelines for authors are in accordance to the above requirements. Papers must be typed double space of the usual dimensions (ISO A4 210×297 mm), with margins of at least 3.5 cm. A separate page must be used for the title, the abstract and keywords, the main text, the acknowledgements, the references, the tables, the figures and the figure legends.

Title page: Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible. It contains (a) the title of the article, which must be brief (up to 12 words), (b) running title up to 50 characters, (c) name and position of the authors(s), (d) institutional affiliation of each author, (e) name, address, telephone number, fax number of the author responsible for correspondence.

Author names and affiliations: Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors’ affiliation addresses (where the actual affiliations with a lower-case superscript letter immediately after the author’s name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.

Corresponding author: Clearly indicate who will handle correspondence at all stages of refereeing and publication. Ensure that phone numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.

Abstract and Key words: A concise and factual abstract is required in English and in Greek. It must include the title, the names of the authors and the institutional affiliation of each author. It should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, references should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract. Abstracts are limited to 250 words with the exception of clinical points of view and case reports whose length is limited to 150 words. The abstracts of the reviews must be descriptive, mentioning all chapters contained and the main conclusions. Abstracts of the original papers, should be structured into four paragraphs, under the following captions: Aim, Material or Patients and Methods, Results, Conclusions. It is important that the quality of the English abstract should be excellent, because it is a major criterion for the acceptance of the journal in the international lists of Biomedical journals

Immediately after the abstract, provide 3-10 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, ‘and’, ‘of’). chosen from the MeSH terms of Index Medicus.

Text: Original papers usually contain the following chapters: Introduction, Material or Patients and Methods, Results, Discussion. The introduction contains the background and the necessary references and cites the objective of the study. The study protocol must be thoroughly described in the methodology section. Details such as the mode of patient or material selection, as well as the methodology applied must be fully disclosed in order that the research may be reproduced by future investigators. In the case of research related to human beings it must be stated that the research was performed according to the principles of the Declaration of Helsinki (1975). The pharmaceutical substances used must be mentioned by their generic names. In the same chapter the data evaluated must be described and the chapter should be completed by an analysis of the statistical criteria used. In the next chapter the results should be presented fully but briefly. Results shown in tables should not be repeated in the text. In the Discussion, the perspectives opened up by the results of the study as well as the final conclusions are discussed. The results must not be repeated in this section. A comparison with the results of other similar studies may be done. The results may also be related to the objectives of the study but it is advisable to avoid arbitrary conclusions, not emerging from the results themselves. Acknowledgements. They are addressed only to persons who have contributed substantially.


References should be identified in the text sequentially in the Vancouver numbering style. The following paradigms illustrate the various reference categories: (From the Michener Institute, University

Journal article, up to 6 personal author(s):

Al-Habian A, Harikumar PE, Stocker CJ, Langlands K, Selway JL. Histochemical and immunohistochemical evaluation of mouse skin histology: comparison of fixation with neutral buffered formalin and alcoholic formalin. J Histotechnol. 2014 Dec;37(4):115-24.

Electronic journal article:

Poling J, Kelly L, Chan C, Fisman D, Ulanova M. Hospital admission for community-acquired pneumonia in a First Nations population. Can J Rural Med [Internet]. 2014 Fall [cited 2015 Apr 27];19(4):135-41. Available from: by selecting PDF link in table of contents.

Electronic journal article, 7 or more personal authors, optional DOI information:

Aho M, Irshad B, Ackerman SJ, Lewis M, Leddy R, Pope T, et al. Correlation of sonographic features of invasive ductal mammary carcinoma with age, tumor grade, and hormone-receptor status. J Clin Ultrasound [Internet]. 2013 Jan [cited 2015 Apr 27];41(1):10-7. Available from: DOI: 10.1002/jcu.21990

Book, personal author(s):

Buckingham L. Molecular diagnostics: fundamentals, methods and clinical applications. 2nd ed. Philadelphia: F.A. Davis; c2012.

Book or pamphlet, organization as both author and publisher:

College of Medical Radiation Technologists of Ontario. Standards of practice. Toronto: The College; 2011.

Book, editor(s):

Kumar V, Abbas AK, Aster JC, editors. Robbins basic pathology. 16th ed. Philadelphia: Elsevier Saunders; c2013.

Book, editor(s), specific chapter with individual author(s):

Altobelli N. Airway management. In: Kacmarek R, Stoller JK, Heuer AJ, editors. Egan’s fundamentals of respiratory care. 10th ed. St. Louis: Saunders Mosby; c2013. p. 732-86.

Electronic book, personal author(s), requiring password:

Martin A, Harbison S, Beach K, Cole P. An introduction to radiation protection [Internet]. 6th ed. London: Hodder Arnold; 2012 [cited 2015 May 28]. Available from: with authorized username and password.

Electronic book, organization as author, freely available:

Open Stax College. Anatomy & physiology [Internet]. Version 7.28. Houston: The College; 2013 Apr 25 [Updated 2015 May 27; cited 2015 May 28]. Available from:

Dictionary entry:

Stedman’s medical dictionary for the health professions and nursing. 7th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; c2012. Hematoma; p. 756.

Entry in a print reference work:

Canadian Pharmacists Association. CPS 2013: compendium of pharmaceuticals and specialties. 48th ed. Ottawa: The Association; c2013. Atropine: Systemic; p. 297-9.

Entry in an online reference work:

Canadian Pharmacists Association. eCPS. [Internet]. Ottawa: The Association; 2015. Methimazole; [revised 2012 Mar; cited 2015 May 28]; [about 6 screens]. Available from: with authorized username and password.

Wiki entry:

Wikipedia: the free encyclopedia [Internet]. St. Petersburg (FL): Wikimedia Foundation, Inc. 2001 – Ebola virus epidemic in West Africa; [modified 2015 May 28; cited 2015 May 28]; [about 34 screens]. Available from:

Newspaper article:

Carville O. Health ‘snooping’ cases on the rise. Toronto Star. 2015 May 27:Sect. GT:1 (col. 3).

Electronic newspaper article:

Wisniewski M. Five babies at Chicago daycare diagnosed with measles. Globe and Mail [Internet]. 2015 Feb 5 [cited 2015 Feb 6]; Life:[about 2 screens]. Available from:

Legal material (note: this is not addressed in Vancouver Style):

Accessibility for Ontarians with Disabilities Act, S.O. 2005, c.11 [Internet]. 2009 Dec 15 [cited 2015 May 29]. Available from:

Report available on a web page:

Canadian Institute for Health Information. Depression among seniors in residential care [Analysis in brief on the Internet]. Ottawa: The Institute; 2010 [cited 2015 May 29]. 18 p. Available from:

Page on a website:

Alzheimer Society of Canada [Internet]. Toronto: The Society; c2015. Benefits of staying active; 2013 Jan 28 [cited 2015 May 29];[about 1 screen]. Available from:

Streaming video:

Allen S, Waerlop I. The Gait Guys talk about great toe dorsiflexion [Internet]. [place unknown]: The Gait Guys; 2014 May 11 [cited 2015 May 29]. Video: 3 min. Available from:

Electronic image:

Bickle I. Swallowed foreign body [radiograph]. 2014 Jul 14 [cited 2015 May 29]. In: [Internet]. [place unknown]:; c2005-2015. [about 1 screen]. Available from:

Blog post (no given name, so screen name used as author):

Munkee. Nuclear Munkee. [blog on the Internet]. [place unknown]: [Munkee]; [date unknown] – . In-111 pentetreotide imaging; 2013 Mar 19 [cited 2015 May 29]; [about 3 screens]. Available from:

Poster presentation/session presented at a meeting or conference:

Chasman J, Kaplan RF. The effects of occupation on preserved cognitive functioning in dementia. Poster session presented at: Excellence in clinical practice. 4th Annual Conference of the American Academy of Clinical Neuropsychology; 2006 Jun 15-17; Philadelphia, PA.

Tables: They are typed double-space, in a separate page. They are numbered by the order they appear in the text, with Arabic numbers. They should have a brief, comprehensive explanation so that the reader need not turn to the text. Each column must have a brief explanatory heading. Explanations of the abbreviations should be made at the bottom of the table.

Figures: If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply ‘as is’ in the native document format. Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please ‘Save as’ or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below): PDF or JPEG.

Images: It is extremely important that a high enough file resolution is used. All separate images that you import into a figure file must be at the correct resolution before they are placed. Note, however, that the higher the resolution, the larger the file and the longer the upload time. Publication quality will not be improved by using a resolution higher than the minimum. Keep to a minimum of 300 dpi Vector drawings, embed all used fonts.

Please do not:

Supply files that are optimized for screen use (e.g.,GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors;

Supply files that are too low in resolution.

Submit graphics that are disproportionately large for the content.

Whilst it is accepted that authors sometimes need to manipulate images for clarity, manipulation for purposes of deception or fraud will be seen as scientific ethical abuse and will be dealt with accordingly. No specific feature within an image may be enhanced, obscured, moved, removed, or introduced. Adjustments of brightness, contrast, or color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original.

Figure legends: On initial submission, each legend should be placed in the text file and be incorporated into the image file beneath the figure to assist review. Legends should provide enough information so that the figure is understandable without frequent reference to the text. However, detailed experimental methods must be described in the Materials and Methods section, not in a figure legend. A method that is unique to one of several experiments may be reported in a legend only if the discussion is very brief (one or two sentences). Define all symbols used in the figure and define all abbreviations that are not used in the text.

Terms and units of measurement: The authors must use the universally accepted terms and the SI units of measurement. For the choice of terms and names (of substances, entities, organizations, diseases etc.) please consult the MeSH of Index Medicus.

Acknowledgements: Collate acknowledgements in a separate section at the end of the article before the references. List here those individuals who provided assistance during the research.

Math formulae: Present simple formulae in the line of normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of “e” are often more conveniently denoted by exp. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the text).

Footnotes: Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many word processors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes in the reference list.

Reprints: Photocopy reproduction of published papers is not allowed.

General Information

Papers submitted to “Journal of Atherosclerosis Prevention and Treatment” are judged for publication on the condition that the results or the paper itself have not been previously published or submitted for publication in another journal.

The corresponding author should report in the cover letter that the research work has not been published or submitted for publication in an other journal. An exception to this rule is the final research results that have been published as preliminary results or as an abstract form. In this case, the author(s) should also submit electronically these previous publications in a PDF form.

Submission of papers

Papers submitted to the journal should be written in english with a greek abstract. All manuscripts should be submitted electronically to the Journal’s website

For any further information you may need please contact the editorial secretariat Dr Tellis Constantinos (Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, 45 110 Ioannina, Greece, Τel.: +30 26510 08326, Fax: +30 26510-08785, Ε-mail:

All manuscripts must be accompanied by a letter, signed by the author responsible for correspondence. The cover letter should include a statement, indicating that the manuscript has been approved by all authors.

Copyright Transfer

Papers published in “Journal of Atherosclerosis Prevention and Treatment” constitute copyright ownership of the manuscript to the Hellenic Atherosclerosis Society. The corresponding author should submit to the journal the copyright transfer agreement form signed by all authors. In case of submission of an original paper been already published in a foreign journal, it must be clearly stated that the authors have obtained the written permission of the copyright owners, a copy of which must be attached. The final revised text will be resubmitted electronically in WORD and PDF form. All papers published in “Journal of Atherosclerosis Prevention and Treatment” are owned by the journal and are not allowed to be republished without the written consent of the Editor in chief.

Primary publication

Manuscripts submitted to the journal must represent reports of original research, and the original data must be available for review by the editor if necessary. By submitting a manuscript to the journal, the authors guarantee that they have the authority to publish the work and that the manuscript, or one with substantially the same content, was not published previously, is not being considered or published elsewhere, and was not rejected on scientific grounds by another journal. It is incumbent upon the author to acknowledge any prior publication, including his/her own articles, of the data contained in a manuscript submitted to the journal. A copy of the relevant work should be submitted with the paper as supplemental material not for publication. Whether the material constitutes the substance of a paper and therefore renders the manuscript unacceptable for publication is an editorial decision. In the event that the authors’ previously published figures and/or data are included in a submitted manuscript, it is incumbent upon the corresponding author to (i) identify the duplicated material and acknowledge the source on the submission form, (ii) obtain permission from the original publisher (i.e., copyright owner), (iii) acknowledge the duplication in the figure legend, and (iv) cite the original article.

Review Process

All manuscripts are considered to be confidential and are reviewed by the editors, members of the editorial board, or qualified ad hoc reviewers. To expedite the review process, authors should recommend at least two editors and also at least three reviewers (i) who are either Editorial Board members or otherwise qualified scientists who are not members of their institution(s), (ii) who have not recently been associated with their laboratory(ies), and (iii) who could not otherwise be considered to pose a conflict of interest regarding the submitted manuscript. Please provide their contact information where indicated on the submission form. Impersonation of another individual during the review process is considered serious misconduct.

Duties of authors

  1. Reporting standards: Authors of original research papers should present accurately the work performed and provide an objective discussion of its significance. Underlying data should be properly represented in the paper. A paper should contain sufficient detail and references to permit others to replicate the work.
  2. Data Access and Retention:Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data and should in any event be prepared to retain such data for a reasonable time after publication.
  3. Originality and Plagiarism:The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.
  4. Multiple, Redundant or Concurrent Publication:Authors should not publish manuscripts describing essentially the same research in more than one journal or primary publication.
  5. Acknowledgement of Sources:Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.
  6. Authorship of the Paper: Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co – authors while those who have participated in certain substantive aspects of the research should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co – authors are included on the paper and that all co – authors have seen and approved the final version of the paper.
  7. Hazards and Human or Animal Subjects: If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.
  8. Disclosure and Conflicts of Interest: All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
  9. Errors in published works: When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with them to correct the paper.